BioSpace News Archive

Genetown

Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit

Ginkgo Bioworks Inc. announced today that management is scheduled to present at the Jefferies Gene Therapy/Editing Summit on Wednesday, October 27, 2021 at 3:00p.m. Eastern Time .

October 20, 2021
·
1 min read
Drug Development

Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

Numinus Wellness Inc. is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin extract

October 20, 2021
·
5 min read
Business

Marc Schneebaum Joins Avalyn Pharma as Chief Financial Officer

Avalyn Pharma Inc., a biopharmaceutical company focused on development of improved therapies for life threatening pulmonary diseases, announced that Marc Schneebaum has joined the company as Chief Financial Officer.

October 20, 2021
·
4 min read
BioCapital

AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards

AstraZeneca, in partnership with Scientific American Custom Media, today announced the winners of the third annual Cancer Community Awards (or C2 Awards).

October 20, 2021
·
7 min read
Drug Development

Enzychem Lifesciences Announces Positive Results for Phase 2 U.S. Study of EC-18 in Chemoradiation-Induced Oral Mucositis

Enzychem Lifesciences (KOSDAQ: 183490) announced today positive Phase 2 results from a U.S. clinical trial of its lead candidate EC-18 in chemoradiation-induced oral mucositis (CRIOM).

October 20, 2021
·
3 min read
Business

Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

The partnership will allow Saama to accelerate its strategic initiatives, including expanding its go-to-market capabilities and further investing in AI research and development.

October 20, 2021
·
5 min read
Deals

Vertellus Completes Acquisition of IM Chemicals

Vertellus,today announced the completion of its acquisition of IM Chemicals, the intermediates and specialties division of ESIM Chemicals and a leading provider of specialty chemical products serving the pharmaceutical, coatings, and fuel & lubricant markets.

October 20, 2021
·
2 min read
Biotech Beach

NKGen Biotech Announces Acceptance of SNK01 Abstract for Presentation at the 2021 Connective Tissue Oncology Society Annual Meeting

NKGen Biotech today announced that a Phase I study of SNK01 monotherapy in refractory cancers has been accepted for presentation at the Connective Tissue Oncology Society (CTOS) Annual Meeting being held virtually November 10 – 13, 2021.

October 20, 2021
·
1 min read
Business

CytoReason Collaborates with Merck KGaA, Darmstadt, Germany, on Cancer Immunotherapy Drug

CytoReason, today announced a collaboration with German multinational science and technology company, Merck KGaA, Darmstadt, Germany, to profile one of its leading immuno-oncology drugs.

October 20, 2021
·
1 min read
BioCapital

New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics

Sysmex Inostics has developed a new CLIA-validated liquid biopsy test for the detection of Minimal Residual Disease in Acute Myeloid Leukemia.

October 20, 2021
·
4 min read